La et al. carried out an in vitro and in vivo investigation and described how EGCG managed to enhance the sensitivity of colon cancer cells to 5-FU by inhibiting the GRP78/NF-κB/miR-155-5p/MDR1 pathway and by promoting 5-FU accumulation in cancer cells [185]. This evidence concerns the gene HSPA5 and cancer.